Author： Pinto F.M. Magraner J. Ausina P. Anselmi E. Martn J.D. Candenas M.L.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.324, Iss.1, 1997-04, pp. : 125-127
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
An investigation of tachykinin NK 2 receptor subtypes in the rat
By Matuszek M.A. Zeng X.-P. Strigas J. Burcher E.
European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. :
Access to resources
Recommend
Molecular and pharmacological characterization of the murine tachykinin NK 3 receptor
By Sarau H.M. Feild J.A. Ames R.S. Foley J.J. Nuthulaganti P. Schmidt D.B. Buckley P.T. Elshourbagy N.A. Brawner M.E. Luttmann M.A. Giardina G.A.M. Hay D.W.P.
European Journal of Pharmacology, Vol. 413, Iss. 2, 2001-02 ,pp. :
SCH 206272: a potent, orally active tachykinin NK 1 , NK 2 , and NK 3 receptor antagonist
By Anthes J.C. Chapman R.W. Richard C. Eckel S. Corboz M. Hey J.A. Fernandez X. Greenfeder S. McLeod R. Sehring S. Rizzo C. Crawley Y. Shih N.-Y. Piwinski J. Reichard G. Ting P. Carruthers N. Cuss F.M. Billah M. Kreutner W. Egan R.W.
European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. :